Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).

Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).

British journal of haematology (2013-10-18)

Brian T Hill, Paolo Caimi, Tammy Kindwall-Keller, Becky Habecker, Matt Kalaycio

MATERIALS

Product Number

Brand

Product Description

Sigma-Aldrich

2-Fluoroadenine-9-β-D-arabinofuranoside, DNA synthesis and methylation inhibitor

Sigma-Aldrich

Adenine 9-β-D-arabinofuranoside, ≥99%